PCSK9 Monoclonal Antibodies: New Developments and Their Relevance in a Nucleic Acid–Based Therapy Era

PURPOSE OF REVIEW: To report on recent data about PCSK9 monoclonal antibodies and to evaluate their relevance in a nucleic acid–based therapy era for lipid lowering and prevention of cardiovascular disease. RECENT FINDINGS: New methods of PCSK9 inhibition based on nucleic acid therapeutics such as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouni-Berthold, Ioanna, Schwarz, Jonas, Berthold, Heiner K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Nonstatin Drugs (L. Tokgozoglu and A.L. Catapano, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474394/
https://www.ncbi.nlm.nih.gov/pubmed/35900635
http://dx.doi.org/10.1007/s11883-022-01053-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474394/
https://www.ncbi.nlm.nih.gov/pubmed/35900635
http://dx.doi.org/10.1007/s11883-022-01053-3

Ejemplares similares